Average Co-Inventor Count = 10.05
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (12 from 3,933 patents)
12 patents:
1. 10786492 - Formylated N-heterocyclic derivatives as FGFR4 inhibitors
2. 10507201 - Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
3. 10189813 - Formylated N-heterocyclic derivatives as FGFR4 inhibitors
4. 10130629 - Pharmaceutical combinations
5. 9896449 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
6. 9802917 - Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
7. 9533988 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
8. 9266883 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
9. 9051279 - Substituted isoquinolinones and quinazolinones
10. 8859535 - Hydroxy substituted isoquinolinone derivatives
11. 8440693 - Substituted isoquinolinones and quinazolinones
12. 8053457 - 3-imidazolyl-indoles for the treatment of proliferative diseases